Systematic Review
Published on 04 Sep 2025
Oral preventive medications for migraine in adults aged 18–65: a network meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620887
- 4,047 views
12 articles related to "Migraine Prevention"
Articles
Original Research
Published on 25 Apr 2025
Effectiveness of a headache awareness campaign on behavioral change
in Headache and Neurogenic Pain
Frontiers in Neurology
doi 10.3389/fneur.2025.1572541
- 2,024 views
Review
Published on 05 Feb 2019
Treating Chronic Migraine With Neuromodulation: The Role of Neurophysiological Abnormalities and Maladaptive Plasticity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00032
- 14,485 views
- 38 citations
Original Research
Published on 06 Nov 2023
Remote electrical neuromodulation (REN) wearable device for adolescents with migraine: a real-world study of high-frequency abortive treatment suggests preventive effects
in Headache
Frontiers in Pain Research
doi 10.3389/fpain.2023.1247313
- 10,558 views
- 18 citations
Original Research
Published on 06 Jan 2022
Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic Migraine
in Headache and Neurogenic Pain
Frontiers in Neurology
doi 10.3389/fneur.2021.788159
- 11,312 views
- 48 citations
Original Research
Published on 10 Dec 2021
Erenumab for Migraine Prevention in a 1-Year Compassionate Use Program: Efficacy, Tolerability, and Differences Between Clinical Phenotypes
in Headache and Neurogenic Pain
Frontiers in Neurology
doi 10.3389/fneur.2021.805334
- 7,076 views
- 30 citations
Original Research
Published on 06 Aug 2024
Efficacy and safety of levetiracetam for migraine prophylaxis in children: a systematic review and meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1407897
- 3,470 views
- 2 citations
Original Research
Published on 03 Nov 2025
Trends and comparative analysis of the burden of migraine in China and globally from 1990 to 2021: an analysis based on the 2021 global burden of disease study
in Headache and Neurogenic Pain
Frontiers in Neurology
doi 10.3389/fneur.2025.1592224
- 1,341 views
Original Research
Published on 28 May 2020
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
in Headache and Neurogenic Pain
Frontiers in Neurology
doi 10.3389/fneur.2020.00417
- 9,874 views
- 82 citations
Original Research
Published on 09 Jan 2023
Preventive treatment response associated with migraine aura subtypes in a Thai population
in Brain Health and Clinical Neuroscience
Frontiers in Human Neuroscience
doi 10.3389/fnhum.2022.1065859
- 3,399 views
- 2 citations
Original Research
Published on 22 Mar 2023
Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
in Headache and Neurogenic Pain
Frontiers in Neurology
doi 10.3389/fneur.2023.1154420
- 6,935 views
- 29 citations
Original Research
Published on 24 Jan 2019
Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine
in Pediatric Neurology
Frontiers in Neurology
doi 10.3389/fneur.2019.00010
- 10,116 views
- 50 citations